QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: BIOLOGICAL: ETBX-021
Sponsor: NantBioScience, Inc.